Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) Operating Expenses (2016 - 2025)

Historic Operating Expenses for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $13.9 million.

  • InspireMD's Operating Expenses rose 5677.11% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year increase of 5510.07%. This contributed to the annual value of $35.0 million for FY2024, which is 5254.47% up from last year.
  • InspireMD's Operating Expenses amounted to $13.9 million in Q3 2025, which was up 5677.11% from $13.3 million recorded in Q2 2025.
  • InspireMD's Operating Expenses' 5-year high stood at $13.9 million during Q3 2025, with a 5-year trough of $3.4 million in Q1 2021.
  • For the 5-year period, InspireMD's Operating Expenses averaged around $7.0 million, with its median value being $5.8 million (2023).
  • As far as peak fluctuations go, InspireMD's Operating Expenses skyrocketed by 6538.31% in 2021, and later skyrocketed by 316.84% in 2023.
  • InspireMD's Operating Expenses (Quarter) stood at $4.2 million in 2021, then increased by 21.51% to $5.1 million in 2022, then rose by 22.96% to $6.3 million in 2023, then surged by 55.81% to $9.8 million in 2024, then surged by 41.47% to $13.9 million in 2025.
  • Its last three reported values are $13.9 million in Q3 2025, $13.3 million for Q2 2025, and $11.8 million during Q1 2025.